Digestiva is a biotechnology startup founded in 2018 with a focus on enhancing the nutritional efficiency of protein utilization. By utilizing a proprietary class of enzymes, Digestiva aims to boost the absorption of critical amino acids essential for human health. The company's goal is to revolutionize the way humans interact with protein nutrition, especially in the face of a growing global population where efficient protein utilization is increasingly vital for sustaining life on earth.
The most recent financial milestone for Digestiva was its $18.40M Series A investment on 15 July 2024. The investors contributing to this round included Astanor Ventures, The March Group, UC Investments, and Magdalena.
With its innovative approach, cost-effective solution, and unique technology, Digestiva presents a promising opportunity for investment in the biotechnology industry.
